American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Scher
    Scher
  3. Rosen
    Rosen
  4. Berger
    Berger
  5. Motzer
    Motzer
  6. Schultz
    Schultz
  7. Koutcher
    Koutcher
  8. Morris
    Morris
  9. Iyer
    Iyer
  10. Rosenberg
    Rosenberg

Groups

  1. Department of Medicine (514)
  2. Genitourinary Oncology Service (514)
  3. Solid Tumor Oncology Division (514)
  4. GSK Faculty (295)
  5. Human Oncology and Pathogenesis Program (223)
  6. Department of Pathology and Laboratory Medicine (140)
  7. Sloan Kettering Institute Postdocs (139)
  8. Sloan Kettering Institute Faculty (132)
  9. Molecular Pharmacology and Chemistry Program Faculty (114)
  10. Breast Medicine Service (104)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (299)
  2. Meeting Abstract (207)
  3. Editorial (6)
  4. Guidelines (1)
  5. Review (1)
Groups
  1. Department of Medicine (514)
  2. Genitourinary Oncology Service (514)
  3. Solid Tumor Oncology Division (514)
  4. GSK Faculty (295)
  5. Human Oncology and Pathogenesis Program (223)
  6. Department of Pathology and Laboratory Medicine (140)

More Groups

People
  1. David Solit (174)
  2. Howard Scher (139)
  3. Neal Rosen (72)
  4. Michael Berger (63)
  5. Robert Motzer (46)
  6. Jason Koutcher (41)

More People

Years
  1. 2024 (9)
  2. 2023 (10)
  3. 2022 (31)
  4. 2021 (41)
  5. 2020 (41)
  6. 2019 (50)

More Years

Publications
  1. Clinical Cancer Research (273)
  2. Cancer Research (241)

Results (514)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Androgen deprivation therapy drives a distinct immune phenotype in localized prostate cancer
    Journal Article

    Dallos, M. C.; Obradovic, A. Z.; McCann, P.; Chowdhury, N.; Pratapa, A.; Aggen, D. H.; Gaffney, C.; Autio, K. A.; Virk, R. K.; De Marzo, A. M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Evaluating immune checkpoint blockade in metastatic castration-resistant prostate cancers with deleterious CDK12 alterations in the phase 2 IMPACT trial
    Journal Article

    Nguyen, C. B.; Reimers, M. A.; Perera, C.; Abida, W.; Chou, J.; Feng, F. Y.; Antonarakis, E. S.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Immunologic profiling of immune-related cutaneous adverse events with checkpoint inhibitors reveals polarized actionable pathways
    Journal Article

    Lacouture, M. E.; Goleva, E.; Shah, N.; Rotemberg, V.; Kraehenbuehl, L.; Ketosugbo, K. F.; Merghoub, T.; Maier, T.; Bang, A.; Gu, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series
    Journal Article

    Anselmino, N.; Labanca, E.; Shepherd, P. D. A.; Dong, J.; Yang, J.; Song, X.; Nandakumar, S.; Kundra, R.; Lee, C.; Schultz, N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
    Journal Article

    Dorff, T.; Horvath, L. G.; Autio, K.; Bernard-Tessier, A.; Rettig, M. B.; Machiels, J. P.; Bilen, M. A.; Lolkema, M. P.; Adra, N.; Rottey, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
    Journal Article

    Halabi, S.; Guo, S.; Park, J. J.; Nanus, D. M.; George, D. J.; Antonarakis, E. S.; Danila, D. C.; Szmulewitz, R. Z.; McDonnell, D. P.; Norris, J. D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase I study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer progressing on enzalutamide
    Journal Article

    Abida, W.; Hahn, A. W.; Shore, N.; Agarwal, N.; Sieber, P.; Smith, M. R.; Dorff, T.; Monk, P.; Rettig, M.; Patel, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • PD-1 expression on intratumoral regulatory T cells is associated with lack of benefit from anti-PD-1 therapy in metastatic clear-cell renal cell carcinoma patients
    Journal Article

    Denize, T.; Jegede, O. A.; Matar, S.; Al Ahmar, N.; West, D. J.; Walton, E.; Bagheri, A. S.; Savla, V.; Laimon, Y. N.; Gupta, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: